2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1912155706 MD
Verify on CMS →

ROBERT KIMMEL, MD

Endocrinology, Diabetes & Metabolism Physician in PUYALLUP, Washington. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
1K
Medicare Part D claims · 207 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
52%
generic claims · 48% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
93.2547/100
▲ 10 pts above national avg 83.1 · [object Object]
Industry payments
$859.22
40 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: ROBERT KIMMEL, MD is a Endocrinology, Diabetes & Metabolism Physician ([object Object]) practicing in PUYALLUP, Washington with a Medicare Part D prescribing footprint of 1K claims across 207 beneficiaries — 48% brand-name prescribing . Their CMS MIPS Final Score of 93.2547/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities . Industry payments of $859.22 across 40 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: ROBERT KIMMEL, MD reported a CMS MIPS final score of 93.2547 out of 100, above the 83.1 national average, and filed 1,155 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

ROBERT KIMMEL, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

ROBERT KIMMEL, MD at a glance

High performer (top quartile)

NPI registry status

Active

Issued 09/04/2008

NPI 1912155706

Primary specialty

Endocrinology, Diabetes & Metabolism Physician

Mid-sized

7,852 US NPIs in this specialty

Medicare Part D claims

1,155 56% vs specialty avg

2023 prescription claims

Specialty avg: 2,639

MIPS final score

93.2547/100 10.154700000000005% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in Washington

How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Washington providers

Washington providers

Endocrinology, Diabetes & Metabolism Physician share within Washington

1. Endocrinology, Diabetes & Metabolism Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Endocrinology, Diabetes & Metabolism Physician share within Washington

Medicare quality performance — MIPS

ROBERT KIMMEL, MD's 2023 MIPS final score plotted against the Endocrinology, Diabetes & Metabolism Physician national average

High performer (top quartile)
MIPS Final Score
93.2547/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Endocrinology, Diabetes & Metabolism Physician) — 93.2547/100 vs national avg 83.1

0%100%National avg83%93.3%
MIPS final score (Endocrinology, Diabetes & Metabolism Physician) — 93.2547/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

ROBERT KIMMEL, MD is a Endocrinology, Diabetes & Metabolism Physician provider practicing in PUYALLUP, Washington, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD. NPI: 1912155706. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

ROBERT KIMMEL, MD appears in the CMS NPPES registry as a Endocrinology, Diabetes & Metabolism Physician provider holding MD credentials at 1029 E MAIN STE 104, PUYALLUP, WA, 98372, with a listed phone of (253) 446-6977. NPI 1912155706 was issued on 09/04/2008. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what KIMMEL most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,155 prescription claims written by this provider, covering 207 Medicare beneficiaries and totaling roughly $330K in drug spend, split 48% brand-name and 52% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 93.2547/100 for the 2023 performance year (Quality 86.5093), compared with the national average of 83.1.

Endocrinology, Diabetes & Metabolism Physician is a mid-sized specialty nationwide, with 7,852 enrolled providers across 54 states and an average of 2,639 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1029 E MAIN STE 104
PUYALLUP, WA 98372

Provider Details

NPI 1912155706
Specialty Endocrinology, Diabetes & Metabolism Physician
Credentials MD
Gender Male
NPI Issued 09/04/2008

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

93.2547
Final Score
Avg: 83.1
86.5093
Quality
100
Promoting Interoperability

Reporting: Alternative Payment Model

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for ROBERT KIMMEL, MD. Source: openpaymentsdata.cms.gov.

Total received

$859

Largest payer

Novo Nordisk Inc

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Washington WMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~34K Washington medical licensees in 2023 — they are NOT specific to ROBERT KIMMEL, MD. To verify ROBERT KIMMEL, MD's current license status, search the WMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

88
Total board actions, Washington 2023
Across 85 cases
2.59
Actions per 1,000 licensees
Washington statewide rate
probation
Most common action type
31 cases

WMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Washington disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

ROBERT KIMMEL, MD — brand share 48.0%
Specialty average (est.)

48% brand-name claims vs 52% generic, on 1,155 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,155
Total Claims
$330K
Total Drug Cost
207
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
2,404
Total Day Supply
71,152
Brand vs Generic
48% brand / 52% generic
Brand Drug Cost
$307K
Generic Drug Cost
$17K

Patient Demographics

Average Patient Age
72.7 years
Avg HCC Risk Score
1.47
Gender Split
67% female / 33% male
Age Distribution
<65: 17, 65-74: 106, 75-84: 69, 85+: 15

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Levothyroxine Sodium
315
Metformin Hcl
58
Ozempic
Semaglutide
54
Calcitriol
51
Liothyronine Sodium
46
Methimazole
42
Synthroid
Levothyroxine Sodium
37
Levoxyl
Levothyroxine Sodium
29
Testosterone Cypionate
29
Humalog Kwikpen U-100
Insulin Lispro
26

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Endocrinology, Diabetes & Metabolism Physician Overview

How ROBERT KIMMEL, MD fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.

7,852
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,639
Avg Claims per Provider

ROBERT KIMMEL, MD's 1,155 claims are below the specialty average of 2,639.

Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Washington

Other clinicians with the same primary specialty enrolled in Washington, drawn from the same CMS NPPES roster as KIMMEL.

Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is ROBERT KIMMEL, MD's specialty?
ROBERT KIMMEL, MD specializes in Endocrinology, Diabetes & Metabolism Physician and practices in PUYALLUP, Washington. Credentials: MD.
How much does ROBERT KIMMEL, MD prescribe under Medicare Part D?
In 2023, ROBERT KIMMEL, MD wrote 1,155 Medicare Part D claims totaling $330K in drug costs for 207 beneficiaries.
What is ROBERT KIMMEL, MD's Medicare quality score?
ROBERT KIMMEL, MD has a CMS MIPS Final Score of 93.2547/100 (Quality: 86.5093). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is ROBERT KIMMEL, MD located?
ROBERT KIMMEL, MD is located at 1029 E MAIN STE 104, PUYALLUP, WA, 98372. Phone: (253) 446-6977.
What is ROBERT KIMMEL, MD's NPI number?
ROBERT KIMMEL, MD's National Provider Identifier (NPI) is 1912155706, issued on 09/04/2008.
Does ROBERT KIMMEL, MD prescribe more brand-name or generic drugs?
ROBERT KIMMEL, MD's prescribing is 48% brand-name and 52% generic drugs by claim count, with $307K in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US?
There are 7,852 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,639 Medicare Part D claims per year.
What drugs does ROBERT KIMMEL, MD prescribe most often?
Based on 2023 Medicare Part D data, ROBERT KIMMEL, MD's most frequently prescribed drugs include Levothyroxine Sodium, Metformin Hcl, Ozempic. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does ROBERT KIMMEL, MD accept Medicare?
ROBERT KIMMEL, MD appears in CMS Medicare data with 1,155 Part D claims and 207 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify ROBERT KIMMEL, MD's credentials?
ROBERT KIMMEL, MD's NPI is 1912155706 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology